Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT
Zachariah DeFilipp(Emory University), Bronwen E. Shaw(Medical College of Wisconsin), Mutlu Arat(Istanbul Florence Nightingale Hospital), Maxim Norkin(University of Florida Health), Mehdi Hamadani(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), William A. Wood(University of North Carolina at Chapel Hill), Mary E.D. Flowers(City Of Hope National Medical Center), Navneet S. Majhail, Mohamad Mohty(Inserm), K. Scott Baker(Fred Hutch Cancer Center), John A. Snowden(Sheffield Teaching Hospitals NHS Foundation Trust), Yoshihiro Inamoto, José López‐Miranda(Florida State University), Nina Salooja(Imperial College London), Harry C. Schouten, Betty K. Hamilton(Cleveland Clinic), Adriana Seber(Support group for adolescents and children with cancer), Maria Gilleece(Leeds Teaching Hospitals NHS Trust), Adriana K. Malone(Icahn School of Medicine at Mount Sinai), Philip L. McCarthy(Cellular Therapeutics (United Kingdom)), Baldeep Wirk(Boston University), David Greenfield(Sheffield Teaching Hospitals NHS Foundation Trust), Minoo Battiwalla(National Heart Lung and Blood Institute), Rafael F. Duarte(Institut Català d'Oncologia), Amir Steinberg(Mount Sinai Medical Center), Pamela Paplham(Roswell Park Comprehensive Cancer Center), Linda J. Burns(University of Minnesota System), William J. Hogan(Mayo Clinic), John M. Richart(Saint Louis University), Bipin N. Savani(Vanderbilt University Medical Center), Muthalagu Ramanathan(UMass Memorial Health Care), Rammurti T. Kamble(Baylor College of Medicine), Christine Duncan(Dana-Farber Cancer Institute), Gregory A. Hale(Johns Hopkins University), Hélène Schoemans(KU Leuven), Jack W. Hsu(University of Florida Health), Maria Teresa Lupo Stanghellini(Vita-Salute San Raffaele University)
Cited by 64
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k